Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-04-30

Development and characterization of heterogeneous catalysts for the asymmetric systhesis of compound with pharmacological application

Objetivo



The demand of optically pure chiral compounds for medical uses makes necessary the development of new highly selective catalysts. The use of heterogeneous catalysts, capable to operate in a continuous way, implies economical advantages. One of the reactions with considerable interest for the pharmaceutical industry is the hydroformylation of styrene to produce 2-phenylpropanal and 3-phenylpropanal (ethylbenzene is also formed by hydrogenation). The objective of this project is to prepare novel metal (platinum and platinum/tin) SiO2-supported catalysts to get, simultaneously, high selectivity to the branched aldehyde and adequate enantiomeric excess. For this purpose, the metallic surface must be modified by the adsorption of a chiral molecule [(-) DIOP]. In a second stage, the active solids will be characterized by different spectroscopic techniques (FTIR, MAS-NMR, inelastic neutron scattering and surface enhanced Raman spectroscopy) in order to determine the configuration of the modifier. This data, within activity test results, will provide valuable information to prepare catalysts of better performance.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Convocatoria de propuestas

Datos no disponibles

Régimen de financiación

RGI - Research grants (individual fellowships)

Coordinador

UNIVERSITY OF DUNDEE
Aportación de la UE
Sin datos
Dirección
Nethergate
DD1 4HN DUNDEE
Reino Unido
Coste total
Sin datos

Participantes (1)